Summary of Drugs and Schedules

Schedule 1

Includes drugs with no proven or acceptable medical use and a high abuse potential - authorized research only.

Schedule 2

Includes narcotic drugs with a high potential for abuse but with currently accepted medical use in treatment. (Opiates, cocaine, methadone, meperidine, oxycodone, morphine, hydrocodone, fentanyl)

Schedule 2N

Includes non-narcotic drugs with a high potential for abuse, such as amphetamines, phenmetrazine, pentobarbital, methylphenidate, and short-acting barbiturates.

Schedule 3

Includes narcotics in combination with other non-narcotic drugs, such as codeine combined with acetaminophen or aspirin, and buprenorphine.

Schedule 3N

Includes ketamine, anabolic steroids, and central nervous system depressants, such as glutethimide, methyprylon, and barbiturates not listed in other schedules. Also includes anorectant agents not included in other schedules.

Schedule 4

Includes narcotics in combination with other non-narcotic drugs, antidiarrheals, mild CNS depressants, mild CNS stimulants, and tranquilizers. Drugs such as chloral hydrate, meprobamate, phenobarbital, diphenoxylate with atropine sulfate, chlordiazepoxide, diazepam, carisoprodol, midazolam, alprazolam, and phentermine are in this group.

Schedule 5

Includes narcotic cough syrups and ephedrine, pseudoephedrine, and phenylpropanolamine products.

Additional Information

Schedule 2 and Schedule 2N drugs require a properly executed, manually signed prescription or a prescription electronically prepared, signed, and transmitted pursuant to DEA requirements for electronic prescribing of controlled substances. NO REFILLS are permitted on these orders. All other scheduled drugs may be prescribed via written, oral, or DEA-compliant electronic prescription orders. Written prescriptions must be signed by the prescriber. A prescriber may ask an assistant to write or type the prescription or to prepare an electronic prescription but the prescriber is responsible for ensuring that all information is correct and the prescriber must manually or electronically sign the prescription, as appropriate.

For more information, see 657 I.A.C. Chapter 10 - Controlled Substances.

Printed from the Iowa Board of Pharmacy website on March 21, 2018 at 12:09am.